Frailty and sarcopenia in Bogotá: results from the SABE Bogotá Study
- 315 Downloads
Latin American countries like Colombia are experiencing a unique aging process due to a mixed epidemiological regime of communicable and non-communicable diseases.
To estimate the prevalence of frailty and sarcopenia among older adults in Colombia and identify variables associated with these conditions.
Data come from the “Salud Bienestar y Envejecimiento” (SABE) Bogotá Study, a cross-sectional study conducted in 2012 in Bogotá, Colombia. Sociodemographic, health, cognitive and anthropometric measures were collected from 2000 community-dwelling adults aged 60 years and older. Frailty variable was created using the Fried phenotype and sarcopenia following the European Working Group on Sarcopenia in Older People algorithm. Logistic regression analyses were used to identify factors associated with frailty and sarcopenia.
A total of 135 older adults are frail (9.4 %), while 166 have sarcopenia (11.5 %). Older age and female gender have a significant association with both conditions (Frailty: Age OR 1.05, 95 % CI 1.03–1.06, Gender OR 1.44, 95 % CI 1.12–1.84; Sarcopenia: Age 1.04, 95 % CI 1.02–1.07, Gender OR 1.51, 95 % CI 1.05–2.17). Depression was also significantly associated with frailty (OR 1.17, 95 % CI 1.12–1.22), while smoking was significantly associated with sarcopenia (OR 2.38, 95 % CI 1.29–4.37). Finally, higher function, measured by independence in IADL (Instrumental Activities of Daily Living) was significantly associated with less frailty (OR 0.74, 95 % CI 0.64–0.86). Education, higher number of comorbidities, better MMSE score, activities of daily living disability and alcohol consumption were not significantly associated with frailty or sarcopenia.
Frailty, sarcopenia and multimorbidity are overlapping, yet distinct conditions in this sample. There are potentially reversible factors that are associated with frailty and sarcopenia in this sample. Future studies need to analyze the best way to prevent these conditions, and examine individuals that have frailty, sarcopenia and comorbidities to design interventions to improve their quality of life.
KeywordsFrailty Sarcopenia Comorbidity Bogotá Colombia
We would like to thank Miguel Borda MD, and Antonio Arciniegas MD, for their feedback and help with editorial aspects of the manuscript.
Compliance with ethical standards
This study was supported by a grant from the Administrative Department of Science, Technology and Innovation—Colciencias in Colombia, Code 120354531692 and the Pontificia Universidad Javeriana.
Conflict of interest
The authors report no conflict of interest for the current manuscript.
Statement of human and animal rights
All procedures performed in this study were in accordance with the ethical standards of the Pontificia Universidad Javeriana institutional review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 6.Bergman H, Hogan DB, Karunananthan S (2008) Frailty: a clinically relevant concept? Can J Geriatr 11:124–129Google Scholar
- 7.Fried LP, Walston JD (1998) Frailty and failure to thrive. In: Hazzard WR, Blass JP, Ettinger WH Jr, Halter JB, Ouslander J (eds) Principles of geraitric medicine and gerontology, vol 4. McGraw Hill, New York, pp 1387–1402Google Scholar
- 8.Walston J, Hadley EC, Ferrucci L et al (2006) Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J Am Geriatr Soc 54:991–1001CrossRefPubMedGoogle Scholar
- 20.Cesari M, Colloca G, Zamboni V et al (2008) Sarcopenia and frailty in older women. In: Benninghouse BT, Rosset AG (eds) Women and aging: new research, 1st edn. Nova Science Publishers Inc, HauppageGoogle Scholar